表紙
市場調查報告書
商品編碼
980010

精神疾病治療市場 - 各疾病類型、治療藥、流通管道、地區:市場規模、佔有率、展望、機會、分析 (2020-2027年)

Mental Disorder Treatment Market, by Disorder Type, by Medication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

精神障礙中,包含憂鬱症,躁鬱症,思覺失調症,失智症,心的外傷後遺症 (PTSD) 等各種精神障礙。這些精神障礙,以藥物療法或精神療法的幫助治療。這些精神障礙的治療所使用的各種藥,有抗憂鬱症藥,抗焦慮藥,抗精神病藥,精神穩定劑等。

本報告提供全球精神疾病治療市場相關調查,市場概要,市場趨勢,影響市場的因素分析,需求分析,各市場區隔、各地區的市場分析,價格分析,並提供主要企業簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告的說明
  • 市場定義和範圍
  • 摘要整理
  • 市場明細:各疾病類型
  • 市場明細:治療藥
  • 市場明細:各流通管道
  • 市場明細:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,及趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 主要的發展
  • 新產品的銷售/核准
  • 合併收購方案
  • 法規方案
  • 開發平台分析
  • 流行病學
  • PEST分析
  • 醫療費償付

第4章 全球精神疾病治療市場:冠狀病毒(Covid-19)大流行的影響

  • COVID-19:心理健康的影響
  • COVID-19:需求與供給的影響

第5章 全球精神疾病治療市場:各疾病類型

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
    • 憂鬱症
    • 兩極性障礙
    • 思覺失調症
    • 失智症
    • PTSD (心性外傷後遺症)
    • 其他

第6章 全球精神疾病治療市場:各藥物類型

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
    • 抗憂鬱症藥
    • 抗焦慮藥
    • 精神穩定劑
    • 抗精神病藥

第7章 全球精神疾病治療市場:各流通管道

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第8章 全球精神疾病治療市場:各地區

  • 簡介
  • 市場佔有率分析:各國
  • 與前一年同期比較成長分析:各國
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 企業簡介
    • Allergan plc
    • Eli Lilly and Company
    • VistaGen Therapeutics
    • Sanofi SA
    • Novartis International AG
    • Mylan NV
    • Amneal Pharmaceuticals LLC
    • Cipla Ltd
    • Sun Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Limited
    • Lupin Limited
    • Janssen Pharmaceutica
    • Bristol Myers Squibb
    • Sumitomo Dainippon Pharma Co., Ltd
目錄

Title:
Mental Disorder Treatment Market, by Disorder Type (Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, and Others), by Medication (Anti-depressants, Anti-anxiety, Mood Stabilizing Medication, and Antipsychotic Medications), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

The mental disorder include various different types of mental disorders such as depression, bipolar disorder, schizophrenia, dementia, post traumatic disorders, and others. These mental disorders are treated with the help of medications or psycho-therapies. Moreover, various medications used for the treatment of these mental disorders include anti-depressants, anti-anxiety medications, anti-psychotic medications, and mood stabilizing medication.

Market Dynamics

Key companies are focusing on product launches for the treatment of mental disorders such as depression, bipolar disorders to strengthen their position in the global mental disorder treatment market. For instance, in 2017, Lupin Limited, launched its anti-depressant, Bupropion Hydrochloride extended release tablets, indicated for the treatment of major depressive disorder, in the U.S. market.

Key features of the study:

  • This report studies the current scenario as well as the future potential of the global mental disorder treatment market. The market for is segmented on basis of disorder type, medication, distribution channel, and region.
  • This report provides in-depth analysis of the global mental disorder treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
  • It profiles leading players in the global mental disorder treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global mental disorder treatment market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global mental disorder treatment market

Detailed Segmentation:

  • Global Mental Disorder Treatment Market, By Disorder Type:
    • Depression
    • Bipolar Disorder
    • Schizophrenia
    • Dementia
    • Post-traumatic Stress Disorder
    • Others
  • Global Mental Disorder Treatment Market, By Medication:
    • Anti-depressants
    • Anti-anxiety
    • Mood Stabilizing Medication
    • Antipsychotic Medications
  • Global Mental Disorder Treatment Market, By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Mental Disorder Treatment Market, By Region:
    • North America
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Allergan plc.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Eli Lilly and Company
    • VistaGen Therapeutics
    • Sanofi S.A
    • Novartis International AG
    • Mylan N.V.
    • Amneal Pharmaceuticals LLC
    • Cipla Ltd
    • Sun Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Limited
    • Lupin Limited
    • Janssen Pharmaceutica
    • Bristol Myers Squibb
    • Sumitomo Dainippon Pharma Co., Ltd

"*" marked represents similar segmentation in other categories in the respective section

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Disorder Type
  • Market Snapshot, By Medication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Key Developments
  • New Product Launches/Approvals
  • Merger-Acquisition Scenario
  • Regulatory Scenario
  • Pipeline Analysis
  • Epidemiology
  • PEST Analysis
  • Reimbursement

4. Global Mental Disorder Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID 19 Impact on Mental Health
  • COVID 19 Impact on Supply and Demand

5. Global Mental Disorder Treatment Market, By Disorder Type, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Bipolar Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Schizophrenia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Dementia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Post-traumatic Stress Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

6. Global Mental Disorder Treatment Market, By Medication, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Anti-depressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Anti-anxiety
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Mood Stabilizing Medication
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Antipsychotic Medications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

7. Global Mental Disorder Treatment Market, By Distribution Channel, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

8. Global Mental Disorder Treatment Market, By Region, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Allergan plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • VistaGen Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mylan N.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Amneal Pharmaceuticals LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cipla Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Glenmark Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lupin Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Janssen Pharmaceutica
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sumitomo Dainippon Pharma Co., Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies